Harnessing tumor microenvironment immunocytes: Nanomedicine strategies for lung cancer therapy
Authors:
- Jing GaoJGJing Gao
- Yu FengYFYu Feng
- Di WuDWDi Wu
- Ximing LiaoXLXiming Liao
- Jialin YaoJYJialin Yao
- Tian LiTLTian Li
- Muyun WangMWMuyun Wang
- Kun WangKWKun Wang
- Qiang LiQLQiang Li
- Wei GaoWGWei Gao
Open Access
- 1 February 2026
- journal article
- Published by Tsinghua University Press in Nano Research
- Vol. 19 (2)
Abstract
Lung cancer, characterized by high mortality, demands more precise and efficient treatment strategies, while the tumor microenvironment (TME) plays a pivotal role in its progression and therapy resistance. In recent years, nanomedicine has emerged as a promising approach to reprogram the immunosuppressive TME and enhance antitumor immunity. This review comprehensively summarizes the latest advances in targeting key immunocytes, including antigen-presenting cells (APCs), cytotoxic cells, regulatory T cells (Tregs), tumor-associated macrophages (TAMs), myeloid-derived suppressor cells (MDSCs), and tumor-associated neutrophils (TANs), using nanomaterial-based strategies for lung cancer treatment. We discuss the design rationale, targeting mechanisms, and therapeutic benefits of various nanoplatforms, highlighting their potential to improve immune activation and drug delivery while minimizing off-target effects. Additionally, we address current challenges including cellular heterogeneity, inadequate tumor penetration, and immune-related adverse events. Finally, we offer perspectives on the future development of immunocyte-targeted nanomedicines, with an emphasis on biomimetic strategies, multi-target approaches, and clinical translation. This review aims to provide a mechanistic foundation and practical guidance for advancing nano-immunotherapy in lung cancer.Keywords
This publication has 166 references indexed in Scilit:
- A Biomimetic Nanomedicine for Remodeling the Immune Microenvironment to Potentiating Anti‐Tumor TherapyAdvanced Healthcare Materials, 2025
- Tailored Liposomal Nanomedicine Suppresses Incomplete Radiofrequency Ablation‐Induced Tumor Relapse by Reprogramming Antitumor ImmunityAdvanced Healthcare Materials, 2025
- Injectable Responsive Hydrogel Delivery Platform: Enabling High Tissue Penetration and Sonogenetic‐Like Potentiating Anti‐Tumor ImmunotherapyAdvanced Functional Materials, 2024
- Phosphorous Dendron Micelles as a Nanomedicine Platform for Cooperative Tumor Chemoimmunotherapy via Synergistic Modulation of Immune CellsAdvanced Materials, 2022
- Overcoming Chemoimmunotherapy‐Induced Immunosuppression by Assemblable and Depot Forming Immune Modulating NanosuspensionAdvanced Science, 2021
- Translational Nanotherapeutics Reprograms Immune Microenvironment in Malignant Pleural Effusion of Lung AdenocarcinomaAdvanced Healthcare Materials, 2021
- Synergistic Activation of Antitumor Immunity by a Particulate Therapeutic VaccineAdvanced Science, 2021
- T‐Cell‐Mimicking Nanoparticles for Cancer ImmunotherapyAdvanced Materials, 2020
- Targeting Neutrophils for Enhanced Cancer TheranosticsAdvanced Materials, 2020
- A Smart Photosensitizer–Manganese Dioxide Nanosystem for Enhanced Photodynamic Therapy by Reducing Glutathione Levels in Cancer CellsAngewandte Chemie International Edition, 2016